Gland Pharma Ltd. Financial Overview
Gland Pharma Ltd.'s market cap is currently ₹315.14B. The company's EPS TTM is ₹11.2; its P/E ratio is 39.87; and it has a dividend yield of 1.06%. Gland Pharma Ltd. is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is ₹16.02. See an overview of income statement, balance sheet, and cash flow financials.
